R espiratory syncytial virus (RSV)
, 3 an enveloped singlestranded negative sense RNA-containing virus, is the major cause of serious lower respiratory tract disease in children (reviewed in Ref. 1) . It is estimated that 40 -50% of children hospitalized with bronchiolitis and 25% of children with pneumonia are infected with RSV, resulting in 100,000 hospital admissions annually in the US alone (2) . RSV infection is also associated with increased morbidity in children with chronic diseases such as bronchopulmonary dysplasia, cystic fibrosis, and congenital heart malformation (3) . In addition to the acute morbidity, RSV infection in infancy can lead to long-term consequences, since it has been shown to predispose to the development of hyperreactive airway disease (1) , and recurrent episodes of wheezing are often precipitated by subsequent RSV infection (4) .
Although the pathophysiology of RSV-induced airway injury is not well understood, autopsy and in vivo studies suggest that the inflammatory response, triggered by the infection of respiratory epithelial cells, is an essential component (5) . IL-8 is known to be a potent chemoattractant and activator for neutrophils, T cells, basophils, and primed eosinophils (reviewed in Ref. 6 ). High concentrations of IL-8 have been detected in nasal and bronchioalveolar lavage fluids of children with RSV respiratory infections (7, 8) and in middle ear effusions of children with viral otitis media (9) . It is therefore likely that this cytokine plays a major role in the recruitment of inflammatory cells to the lung following infection by RSV.
Using the model of infecting well-differentiated lung type II alveolar epithelial cells (A549), we have previously shown that RSV replication in airway epithelial cells results in increased IL-8 gene expression and protein release (10) . Nuclear run-on assays have shown that the enhanced IL-8 synthesis was primarily due to increased gene transcription. Mutational analysis of the IL-8 promoter demonstrated that NF-B binding was absolutely required for RSV-and TNF-induced IL-8 gene transcription (10, 11) . However, the participation of upstream regulatory elements was not investigated.
Previous studies have shown that regulation of IL-8 gene expression is cell type and stimulus specific (12) . The current view on how a cell can respond dynamically to a variety of different stimuli is that combinations of ubiquitous, signal-and tissue-specific activators can be assembled into a nucleoprotein complex called enhanceosome (13) . In the enhanceosome model, the arrangement of different activator recognition sites and bound activators generates a network of protein-protein and protein-DNA interactions that is unique to a given enhancer for each stimulus. Each enhanceosome provides a specific activation surface that is chemically and spatially complementary to target surfaces of coactivators and to the basal transcriptional machinery; in this way, they can be recruited to DNA to generate synergistic transcription.
In the few studies performed in alveolar epithelial cells, in which the regulation of IL-8 gene transcription after RSV infection was examined, there has been controversy regarding the need for replicating virus, as well as the promoter region required for IL-8 activation (14 -17) . Therefore, the purpose of this study was to clarify which promoter elements are involved in regulation of IL-8 gene transcription following RSV infection and to define whether there are different requirements from cytokine stimulation. Our results indicate that NF-B binding site is not only necessary, but sufficient for activation of IL-8 transcription after TNF stimulation. In contrast, IL-8 induction by RSV infection requires the participation of several additional upstream response elements. Among them we have identified a previously unrecognized regulatory element, with similarity to the consensus IFN-stimulated response element (ISRE), that plays an important role in RSV-activated gene transcription.
Materials and Methods

RSV preparation
The human Long strain of RSV (A2) was grown in Hep-2 cells and purified by centrifugation on discontinuous sucrose gradients, as described elsewhere (18) . The virus titer of the purified RSV pools was 7.5-8.5 log PFU/ml using a methylcellulose plaque assay. No contaminating cytokines, including IL-1, TNF, IL-6, IL-8, GM-CSF, and IFN, were found in these sucrose-purified viral preparations (19) . LPS, assayed using the Limulus hemocyanin agglutination assay, was not detected. Virus pools were aliquoted, quick frozen on dry ice/alcohol, and stored at Ϫ70°C until used.
Cell culture and infection of epithelial cells with RSV
A549, human alveolar type II-like epithelial cells (American Type Culture Collection, Manassas, VA), were maintained in F12K medium containing 10% (v/v) FBS, 10 mM glutamine, 100 IU/ml penicillin, and 100 g/ml streptomycin. Cell monolayers were infected with RSV at multiplicity of infection (MOI) of 1, as described (10) . An equivalent amount of a 20% sucrose solution was added to uninfected A549 cells, as control.
Plasmid construction
The 5Ј deletion constructs of the human IL-8 (hIL-8) promoter were produced by PCR using Ϫ1498/ϩ44 hIL-8 luciferase (LUC) reporter plasmid as a template and a downstream oligonucleotide hybridizing from nt ϩ86 to ϩ55 of the LUC cDNA (10) . Upstream primers were used to produce 5Ј deletions at Ϫ162, Ϫ132, and Ϫ99 nt by incorporating a unique BamHI restriction site immediately upstream. The PCR products were restricted with BamHI and HindIII, gel purified, and subcloned into the poLUC reporter vector (11) .
Site mutations of the IL-8 RSVRE in the context of Ϫ162/ϩ44 hIL-8 promoter were introduced by PCR using the following upstream mutagenic primer (mutations underlined): 5Ј-ACTCCGTATTTGAGGCCCCCCTCT TCTGTGGAT-3Ј and the downstream luciferase oligonucleotide: 5Ј-TTATGTTTTTGGCGTCTTCCATTTTA-3Ј.
Site-directed mutations of the IL-8 NF-IL6 site in the context of Ϫ162/ ϩ44 hIL-8 promoter were introduced using the technique of PCR "SOE-ING" (11) using the following mutagenic primers (mutations underlined): 5Ј-GCCATCAGCTACGAGTCGTGGAATTTCCTCTGA-3Ј and 5Ј-GAA ATTCCACGACTCGTAGCTGATGGCCCATCC-3Ј. For the AP-1 binding site mutation, the primers 5Ј-GAGTGTGATATCTCAGGTTTGCCCTGA-3Ј and 5Ј-CAAACCTGAGATATCACACTTCCTA-3Ј were used.
Multimeric binding sites were constructed by ligation of three copies of the NF-B, 5Ј-GATCCATCAGCTACGAGTCGTGGAATTTCCTCTA-3Ј; AP-1, 5Ј-GATCCGAGTGTGATGACTCAGGTTTGCCCTTTA-3Ј; and NF-IL6, 5Ј-GATCCATCAGTTGCAAATCGTTTAATTTCCTCTA-3Ј DNA sequences (having previously annealed them to complementary overlapping oligonucleotides) upstream of the Ϫ54 hIL-8 LUC promoter. Before ligation, 100 pmol of the duplex oligonucleotides were phosphorylated with T 4 kinase and ligated with T 4 DNA ligase, and trimers were isolated by nondenaturing gel electrophoresis (PAGE).
Plasmids were purified by ion exchange (Qiagen, Chatsworth, CA) or on CsCl gradient and sequenced in their entirety, before transfection, by the dideoxy chain termination method using the Sequenase version 2.0 kit (Amersham, Arlington Heights, IL).
Cell transfection
Logarithmically growing A549 cells were transfected in triplicate in 60-mm petri dishes by DEAE-dextran, as previously described (10) . Cells were incubated in 2 ml of HEPES-buffered DMEM (10 mM HEPES, pH 7.4) containing 20 l of 60 mg/ml DEAE-dextran (Pharmacia) premixed with 6 g IL-8 LUC reporter plasmid and 1 g CMV-␤ galactosidase internal control plasmid. After 3 h, media was removed, and 0.5 ml of 10% (v/v) DMSO in PBS was added to the cells for 2 min. Cells were then washed with PBS and cultured overnight in 10% FBS/DMEM. The next morning, cells were either infected with RSV at MOI of 1 or stimulated with TNF, 20 ng/ml. At 12 h postinfection or 6 h after TNF stimulation, cells were lysed to independently measure luciferase and ␤-galactosidase reporter activity, as previously described (20) . Luciferase was then normalized to the internal control ␤-galactosidase activity. All experiments were performed in duplicate or triplicate, using at least two different plasmid preparations.
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts of uninfected and infected A549 cells were prepared using hypotonic/nonionic detergent lysis, as previously described (10) . To prevent contamination of nuclear extracts with cytoplasmic proteins, isolated nuclei were purified by centrifugation through 1.7 M sucrose buffer A for 30 min, at 12,000 rpm, before nuclear protein extraction. Proteins were normalized by protein assay (Protein Reagent; Bio-Rad, Hercules, CA) and used to bind to duplex oligonucleotides corresponding to the IL-8 RSVRE wild-type (WT) and mutated (MUT; mutations underlined) and to the IL-8 AP-1 binding site: RSVRE (WT), GATCCACCGTATTTGATAAGGAA GAAATAGGAGTGTTA GTGGCATAAACTATTCCTTC TTTA TCC TCACAATCTAG; RSVRE (MUT), GATCCACCGTATTTGATAAGG CCCCCCTCTTCTGTGGAGTGGCATAAACTATTCCGGGGGGAGAA GACACCTCTAG; AP-1, GATCCGAGTGTGATGACTCAGGTTT GC CCTTA GCTCACACTACTGAGTCCAAACGGGAATCTAG.
Nuclear extracts, used for binding to the AP-1 site, were prepared form control and infected A549 cells that have been serum starved, before and throughout the period of infection, for a total of 24 h.
DNA-binding reactions using the RSVRE probe contained 10 -15 g total protein, 5% glycerol, 12 mM HEPES, 80 mM NaCl, 5 mM DTT, 1 g of poly(dA-dT), and 40,000 cpm of 32 P-labeled double-stranded oligonucleotide in a total volume of 20 l. Binding reactions for the AP-1 probe contained 10 -15 g total protein, 5% glycerol, 12 mM HEPES, 80 mM NaCl, 5 mM DTT, 5 mM MgCl 2 , 0.5 mM EDTA, 1 g of poly(dI-dC), and 40,000 cpm of 32 P-labeled double-stranded oligonucleotide in a total volume of 20 l. The nuclear proteins were incubated with the probe for 15 min at room temperature and then fractionated by 6% nondenaturing PAGE in TBE buffer (22 mM Tris-HCl, 22 mM boric acid, 0.25 mM EDTA, pH 8). In competition assays, 10 pmol of unlabeled competitors were added at the same time of probe addition. After electrophoretic separation, gels were dried and exposed for autoradiography using Kodak XAR film at Ϫ70°C using intensifying screens.
Microaffinity isolation assay
A549 cells were labeled overnight with [
35 S]methionine and [ 35 S]cysteine and harvested to prepare nuclear extracts. Microaffinity purification of proteins binding to RSVRE was performed using a two-step biotinylated (Bt) DNA-streptavidin capture assay (11) . In this assay, duplex oligonucleotides were chemically synthesized containing 5Ј Bt on a flexible linker (Genosys, The Woodlands, TX). Five hundred micrograms of nuclear extracts were incubated with 50 pmol of duplex oligonucleotide in the presence of 8 g poly(dA-dT) (as nonspecific competitor) in 1000 l (final volume) of binding buffer (8% (v/v) glycerol, 5 mM DTT, 80 mM NaCl, 12 mM HEPES (pH 7.8), at 4°C for 30 min. One hundred microliters of a 50% slurry of prewashed streptavidin-agarose beads were then added to the sample, and incubated at 4°C for an additional 20 min with gentle rocking. Pellets were washed twice with 500 l binding buffer, and proteins were eluted from beads with 100 l of 1 M NaCl. Proteins were desalted on a G50 column and incubated again with the oligonucleotides. The washed pellets were resuspended in 100 l 1ϫ SDS-PAGE buffer, boiled, and fractionated on a 10% SDS-polyacrylamide gel. After electrophoretic separation, gels were dried and exposed for autoradiography using Kodak XAR film at Ϫ70°C using intensifying screens.
In the microaffinity isolation/Western blot assay, RSVRE-binding proteins were isolated from control and 12-h RSV-infected nuclear extracts, as previously described, in the absence or presence of 10-fold molar excess of nonbiotinylated RSVRE WT oligonucleotide. After electrophoresis separation, proteins were transferred to polyvinylidene difluoride membrane for Western blot analysis.
Western immunoblot
Cytoplasmic and nuclear proteins were prepared as previously described, fractionated by SDS-PAGE, and transferred to polyvinylidene difluoride membranes (11) . Membranes were blocked with 5% albumin in TBSTween and incubated overnight with a rabbit polyclonal Ab to IRF-1 (Santa Cruz Biotechnology, Santa Cruz, CA). For secondary detection, we used a horseradish-coupled donkey anti-rabbit Ab in the enhanced chemiluminescence assay (Amersham).
Statistical analysis
Data from experiments involving multiple samples subject to each treatment were analyzed by the Student Newman Keuls t test for multiple pairwise comparisons.
Results
Effects of 5Ј deletions in the IL-8 promoter sequence on RSV and cytokine-inducible activity
To define the regions of the IL-8 promoter involved in regulating gene expression after RSV infection or TNF stimulation, A549 cells were transiently transfected with plasmids containing serial deletions of the 5Ј flanking region of the IL-8 gene, linked to the luciferase reporter gene. A schematic diagram of the promoter is shown in Fig. 1 . We have previously shown that a Ϫ162/ϩ44 nt fragment retains the same RSV and TNF inducibility as longer fragments of the IL-8 promoter (up to Ϫ1.4 kb) (10) . Luciferase activity was measured after 12 h of RSV infection or 6 h of TNF stimulation, time points that we have previously shown to correspond to peak reporter gene induction after each stimulus (10, 11) . As shown in the Fig. 2A , RSV infection induced luciferase activity of the Ϫ162/ϩ44 hIL-8/LUC by 6.7-fold compared with uninfected cells. Deletion from Ϫ162 to Ϫ132 nt reduced to half the inducibility of the luciferase activity (3.7-fold), without affecting basal activity, suggesting the presence of a positive regulatory element in this region of the promoter. Further deletion to Ϫ99 nt reduced the basal activity of the promoter by 2-3-fold and completely abolished the RSV-induced luciferase activity, indicating that the sequence between Ϫ132 and Ϫ99 nt is also critically involved in IL-8 gene activation by RSV. TNF was also a potent inducer of IL-8 transcription, producing a 35-fold increase of the Ϫ162/ϩ44 hIL-8/LUC (Fig. 2B) . The 5Ј deletion to Ϫ132 nt did not affect the response of the IL-8 promoter to TNF stimulation. Deletion to Ϫ99 nt did not change the TNF stimulation of the promoter in terms of fold induction (43-fold), although the overall activity of the promoter was reduced in proportion to the reduction of the basal activity. A further deletion to Ϫ54 nt instead greatly diminished, although did not completely abolish, the TNF-induced luciferase activity, demonstrating that the region from Ϫ99 to Ϫ54 nt is required for IL-8 gene activation by TNF. These data indicate a stimulus-selective role for two regions in the IL-8 promoter upstream of Ϫ99: 1, a region between Ϫ132 and Ϫ99 nt, that contains a functional AP-1 binding site; and 2, a region from Ϫ162 to Ϫ132 nt, which has not been investigated. Because this latter region functions as a positive regulatory element only in RSV infection, we term it RSVRE. Therefore, while the presence of RS-VRE and AP-1 binding sites is necessary for RSV inducibility of the IL-8 promoter, TNF inducibility of the promoter stimulation mainly requires an intact NF-B/NF-IL6 binding site.
Binding of nuclear factors to the RSVRE and AP-1 sites of the IL-8 promoter
We have previously shown that RSV infection as well as TNF stimulation of A549 cells resulted in increased binding of the subunits RelA, NF-B1, and c-Rel to the IL-8 NF-B site (10, 11) . Because the 5Ј deletion analysis of the promoter showed that the RSVRE and the region containing an AP-1 binding site are two important regulatory elements in RSV-induced IL-8 transcription, we performed EMSA to determine whether RSV infection produced changes in the abundance of DNA-binding proteins that recognize these two regions of the IL-8 promoter. As shown in Fig.  3A , a single nucleoprotein complex (C3) was formed by sucrose cushion-purified control nuclear extracts, using the oligonucleotide corresponding to the RSVRE, while two other complexes, termed C1 and C2, were faintly detected. RSV infection increased the binding of C1 and C2 starting at 6 h postinfection, with a peak in binding intensity at 12 h postinfection. The sequence specificity of the RSVRE complexes was examined by competition with unlabeled oligonucleotides in EMSA (Fig. 3B ). C1 and C2 were competed by the WT oligonucleotide, but not by the MUT one, indicating binding specificity. Specificity was also shown by the absence of C1 and C2 binding to the radiolabeled RSVRE MUT probe. Analysis of the RSVRE sequence identified two potential sites for transcription factor binding: a GATA site between Ϫ151 and Ϫ147 nt, and a site between Ϫ144 and Ϫ132 nt, containing an ISRE-like motif in the sense strand and a HNF-3b-like motif in the minus strand (21) (22) (23) . Mutation of the GATA site did not affect RSVRE-binding and competition assays, using oligonucleotides corresponding to consensus sequences of GATA and HNF binding sites, could not identify the RSVRE as one of them, as neither site could compete for C1/C2 binding (data not shown).
To better characterize the nuclear proteins binding to the RSVRE, we performed microaffinity isolation assay of radiolabeled nuclear proteins. In this assay, Bt WT and MUT RSVRE duplex oligonucleotides were used to bind 35 S-labeled A549 nuclear extracts. RSVRE-binding proteins were captured by the addition of streptavidin-agarose beads, washed, eluted from the beads, fractionated by SDS-PAGE, and detected by autoradiography. As a negative control, we used an unrelated Bt probe of similar length, APRE-M2 (20) . As shown in Fig. 4 , one protein of ϳ70 kDa and two of 50 -55 kDa bind specifically to the RSVRE WT probe. These proteins were not captured by the Bt RSVRE MUT or unrelated APRE-M2 probes.
To determine whether RSV infection produced changes in the abundance of DNA-binding proteins recognizing the IL-8 AP-1 site, nuclear extracts prepared from serum-starved control and RSV-infected A549 cells were used for EMSA. As shown in the left panel of Fig. 5 , a faint AP-1-binding complex was detected in control A549 cells and was further increased by RSV infection. The binding to the AP-1 site was sequence specific, as it was competed by the addition of 10 pmol of unlabeled oligonucleotide (Fig. 5, right panel) .
IRF-1 is a component of the RSVRE-binding complex
As analysis of the RSVRE sequence revealed the presence of an ISRE-like site, we sought to investigate whether RSV infection of A549 cells could activate the viral-inducible transcription factor IRF-1, which modulates transcription of ISRE-containing genes, such as human IFN-␤ (24). Western blot was performed on cytoplasmic and sucrose cushion-purified nuclear extracts of A549 cells control and infected for various length of time. IRF-1 protein was expressed at low levels in the cytoplasm and nucleus of control cells and was highly inducible following RSV infection, starting between 3 and 6 h postinfection, as shown in Fig. 6 .
To determine whether IRF-1 was binding to the IL-8 RSVRE, we used a two-step microaffinity isolation/Western blot assay. In this assay, Bt RSVRE was used to bind nuclear extracts of control and 12-h infected A549 cells. RSVRE-binding proteins were captured by the addition of streptavidin agarose beads and washed, and the presence of bound IRF-1 was detected by Western blot. As shown in Fig. 7 , little IRF-1 was detectable in control cells, but its abundance was greatly increased after RSV infection. IRF-1 detection was reduced when 10-fold excess of nonbiotinylated RSVRE WT oligonucleotide was included as competitor in the initial binding reaction, indicating sequence specificity. 
Effects of site mutations in the promoter on IL-8 gene activation by RSV infection and cytokine stimulation
To establish precisely the role of the individual cis elements of the IL-8 promoter in conferring responsiveness to either RSV infection or TNF stimulation, we introduced site-directed mutations of these sites in the context of the Ϫ162 hIL-8 promoter. These mutations correspond to sequences known to disrupt binding of the relevant transcription factor (Fig. 3) (11) . A549 cells were transiently transfected with the WT and MUT plasmids, and luciferase activity was measured after 12 h of RSV infection or 6 h of TNF stimulation. As shown in Fig. 8A , the RSV-induced promoter activity was reduced to ϳ55% of wild type by site mutations of the RSVRE site. Mutation of the AP-1 site affected both the basal activity and the RSV inducibility of the promoter, the latter being reduced to ϳ50%. The NF-IL6 site mutant also showed lower inducibility (60% reduction) compared with the WT promoter, with no effect on the basal activity. When we introduced simultaneous mutations of RSVRE and either the AP-1 or the NF-IL6 binding site, the IL-8 promoter was no longer inducible following RSV infection. These results suggest that all three binding sites contribute to IL-8 promoter induction after RSV infection, and that cooperation among these different sites is required for full activation of the promoter.
When cells were stimulated with TNF (Fig. 8B) , the AP-1 site mutant showed a similar fold induction compared with the wild type, and the NF-IL6 site mutant only a modest reduction of the luciferase activity, suggesting that the NF-B site is sufficient to confer TNF inducibility to the IL-8 promoter.
RSV infection requires the combination of multiple promoter elements to activate transcription
To determine whether these sites could be independently induced by RSV infection or TNF stimulation, A549 cells were transfected with reporter genes containing multimers of the IL-8 AP-1, NF-B, or NF-IL6 elements ligated upstream of the IL-8 TATA box. As shown in Fig. 9 , activity of the NF-B multimer was highly inducible (18-fold) by TNF, whereas the other sites were not significantly affected by TNF stimulation. Although the AP-1 site was not TNF inducible, it was strongly induced (ϳ8-fold) by the diacylglycerol agonist, PMA. In contrast, although RSV infection was able to activate the Ϫ162/ϩ44 hIL-8/LUC expression, it was unable to stimulate the reporter activity of any isolated multimer. These data suggest that the NF-B site is the TNF-inducible element of the IL-8 promoter, whose presence is both necessary and At different time points after infection, cells were harvested to prepare cytoplasmic and nuclear extracts, and equal amounts of protein from control and infected cells were assayed for IRF-1 by Western blot. IRF-1 protein is present both in the cytoplasm and nucleus of control cells and is increased following RSV infection. The molecular mass (in kDa), determined by coelectrophoresed standards, is indicated on the right.
FIGURE 7.
Microaffinity isolation/Western blot for IRF-1. Control and 12-h infected A549 nuclear extracts were affinity purified using Bt RSVRE in the absence or presence of nonbiotinylated WT RSVRE competitor. After capture with streptavidin-agarose beads, complexes were eluted and assayed for IRF-1 by Western blot. A band of 48 kDa is faintly detected in control nuclear extracts and increases after RSV infection. Binding is competed by the nonbiotinylated oligonucleotide, indicating sequence specificity of the binding. sufficient for TNF-activated IL-8 gene transcription. They also indicate distinct, combinatorial requirements for RSV-induced IL-8 transcriptional activation.
To further investigate the interaction among the different regions of the IL-8 promoter needed in RSV infection to activate gene transcription, we transfected A549 cells with plasmids containing either a copy of the RSVRE together with a copy of the AP-1 site upstream the Ϫ99/ϩ44 hIL-8 promoter (which itself is not RSV inducible), or two copies of the RSVRE (Fig. 10A) . The results showed that the RSVRE could partially restore the RSV inducibility of the Ϫ99/ϩ44 hIL-8 promoter, as shown in Fig. 8B . These data confirm that RSV induction of IL-8 transcription requires the participation of additional cis elements, implying the requirement of a distinct network of protein-protein and protein-DNA interactions than those required for cytokine stimulation.
Discussion
Under normal conditions, airway epithelial cells represent an important interface between the external environment and the host. Upon infection or injury, they play an important role in initiating the mucosal immune response by producing soluble factors, such as cytokines, that regulate communication among cells of the immune system. The immunomodulatory activity of the airway epithelium is of particular relevance to RSV infection, because the inflammatory response triggered by RSV infection seems to be an essential pathogenic component of RSV-induced lung damage (5) .
Chemokines are a novel class of small cytokines that are able to recruit and activate leukocytes, and therefore have a significant role as potent mediators of immune/inflammatory responses (25) . The C-X-C chemokine IL-8, in particular, is likely to play a major role in the pathogenesis of RSV infection because it is a strong chemoattractant for the majority of inflammatory cells present in the cellular infiltrate of RSV-infected lungs (6, 26) , and it has been detected in nasal and bronchial lavage fluids of children infected with RSV (7, 8) .
We have previously shown that RSV infection and TNF stimulation of alveolar epithelial cells strongly induce IL-8 gene expression and protein release (10, 11) . The enhanced protein synthesis was primarily due to increased gene transcription, and both stimuli required NF-B activation for gene expression. The mechanisms of IL-8 gene induction have been investigated in a variety of cell types, and deletion and mutational analysis of the promoter indicates that IL-8 gene is activated in a cell-type and stimulusspecific manner (12) , suggesting that different sets of nuclear factors might be necessary for IL-8 gene transcription. Because identification of the pleiotropic mechanisms required for IL-8 promoter activation is important for rational design of therapeutic agents that can block its expression in the lung, in this study we performed a detailed analysis of IL-8 promoter activation in airway epithelial cells comparing two important proinflammatory stimuli, RSV infection and TNF stimulation.
Analysis of promoter deletions indicates that the region from nt Ϫ99 to ϩ44 is necessary and sufficient for TNF-induced IL-8 transcription. On the other hand, RSV-induced IL-8 activation requires the participation of a previously unrecognized response element spanning from Ϫ162 to Ϫ132 nt, which we term the RSV response element (RSVRE), and a previously characterized element spanning Ϫ132 to Ϫ100 nt, containing a functional AP-1 binding site. Several studies have investigated the minimal enhancer region of the IL-8 promoter necessary to confer the responsiveness to cytokines such as TNF and IL-1. In human cells derived from fibrosarcoma, astrocytoma, and glioblastoma tumors, as well as in Hela cells, TNF activates IL-8 through a cis element encompassing Ϫ97 to Ϫ69 nt, a region that contains the NF-IL6 and NF-B sites (27, 28) , similarly to what we have observed in the alveolar epithelial cells. However, the presence of these two binding sites is not always sufficient for IL-8 gene activation. An intact AP-1 binding site, located from Ϫ126 to Ϫ120 nt, is in fact required for TNF induction of the IL-8 promoter in gastric cancer cells, hepatoma cells, and Jurkat T cells, as well as in a lung epithelial cell line (29, 30) . These results suggest that the combination of the minimal enhancer region essential for TNF-induced IL-8 gene activation differs among cell types, possibly due to a different distribution of transcription factors or coactivators of transcription.
Our observation that RSV infection of alveolar epithelial cells requires the presence of two additional regulatory elements for full promoter inducibility, compared with TNF stimulation, indicates the presence of stimulus-specific requirements for IL-8 gene induction within the same cell type. Previous work in alveolar epithelial cells has shown similar inducibility of the Ϫ132 and Ϫ99/ ϩ44 IL-8 promoters after both RSV infection and TNF stimulation (14 -16) . These studies have also shown IL-8 gene induction with inactivated RSV. In our hands, the UV-inactivated virus is unable to induce IL-8 gene expression (10) , and indeed the deletion of the Ϫ162 to Ϫ132 nt region strongly reduces the RSV inducibility of the IL-8 promoter, while a further deletion to Ϫ99 nt completely abrogrates it. The differences of our study compared with the previous ones might be explained by their use of nonpurified viral preparations, known to be contaminated by IL-1␣ and possibly TNF (19) , extremely potent IL-8 and NF-B stimulants, and by the use in transient transfection assays of a nonquantitative reporter gene, such as the chloramphenicol acetyl transferase, in which subtle differences could be missed (31) .
The results of site-directed mutation experiments clearly show that the RSVRE, AP-1, and NF-IL6 binding sites are all necessary for RSV-induced activation of the IL-8 promoter, while TNF stimulation requires mainly an intact NF-B site. Our data are in agreement with previous studies showing that AP-1 and NF-IL6 binding sites are important in RSV-induced IL-8 promoter activity (14, 15) . However, our results also indicate the involvement of a previously unidentified regulatory element of the IL-8 promoter, the RSVRE, that plays an important role in activation of IL-8 gene expression during RSV infection. The RSVRE shows sequence similarity with the consensus ISRE site, and our results suggest that can bind the transcription factor IRF-1, which is activated in A549 cells following RSV infection. IRF-1 belongs to a growing family of transcription factors, the IRFs. To date, 10 members of this family have been identified, and their expression is either constitutive and/or inducible after IFN/cytokine stimulation or in response to viral infection (24) . IRF-1 is of particular interest, as this virus-inducible protein activates IFN-␤, a gene highly expressed in RSV-infected epithelium (M. Jamaluddin, unpublished data). Interestingly, on the IFN-␤ gene, IRF-1 activates transcription only when NF-B is coexpressed (32) , indicating a common mechanism of activation with our studies on IL-8. Our observation extends the sites that cooperate with IRF-1 to include NF-IL6 and AP-1. Whether these sites are promoter/context specific or is a more general requirement of IRF-1 will need further investigation. Our data also show that IRF-1 is binding within a larger complex with additional proteins because we observed an unknown 70-kDa protein in the microaffinity-binding assay (Fig. 4) . Future studies will determine whether other members of the IRF family, such as IRF-3 and IRF-7, which have also been shown to play an important role in IFN-␤ gene induction (33) , can bind to the RSVRE and regulate IL-8 promoter activation following RSV infection. The RSVRE is not only stimulus specific, but is possibly also cell type specific, because we were not able to demonstrate its involvement in IL-8 gene regulation in a similar model of intestinal epithelial cells infected with rotavirus (A. Casola, unpublished data).
Several studies have suggested an important role for NF-IL6 in cytokine-induced IL-8 promoter activation (27, 34, 35) . Our mutational experiments show only a modest reduction of TNF inducibility of the NF-IL6-MUT Ϫ162/ϩ44 IL-8 LUC, suggesting that the NF-B site is the major regulatory element in TNF-induced IL-8 activation. Furthermore, we were not able to show NF-IL6 binding after TNF stimulation, either by gel-shift assay or microaffinity isolation (11) . A possible explanation is that the role of NF-IL6 was tested in the context of the Ϫ162/ϩ44 IL-8 promoter. In this study, other binding sites, such as AP-1, could have redundant activity and could be used alternatively for NF-IL6 site.
Further evidence that the mechanisms of activation of IL-8 promoter are different in the RSV infection and TNF stimulation is provided by the results of transient transfections of IL-8 multimer binding sites. Although TNF is able to stimulate the reporter activity of plasmids containing multimers of the NF-B site, and not of the NF-IL6 and AP-1 sites, none of the multimers is activated by RSV infection. The RSV-induced reporter activity is instead partially reconstituted by the addition of the RSVRE to the uninducible Ϫ99/ϩ44 IL-8 promoter, suggesting again that RSV infection requires a different network of protein-protein and protein-DNA interactions to activate IL-8 gene transcription, in comparison with cytokine stimulation. Although both TNF and RSV can induce NF-B nuclear translocation and DNA binding, the ability of NF-B to transactivate the IL-8 promoter is different between the two stimuli. This difference in NF-B activation could be due to the induction of distinct intracellular signaling pathways affecting posttranslational modifications of NF-B and the recruitment of different coactivators to the IL-8 promoter. The activity of transcription factors is regulated at multiple levels: the level of synthesis, subcellular localization, and posttranslational modifications. RelA/p65 has been shown to be phosphorylated either constitutively or in an inducible manner by stimuli such as LPS, IL-1, and TNF (36 -38) . This event has been associated with an increase in p65 transcriptional activity, without modification of nuclear translocation or DNA-binding affinity, and with increased association with the coactivators p300/CPB (37) .
Our findings that multiple binding sites contribute to the IL-8 promoter induction after RSV infection and that cooperation among these different sites is required for full activation of the promoter support the enhanceosome model for IL-8 gene transcription. An enhanceosome is a nuclear protein complex assembled at a given enhancer, in which various combinations of ubiquitous, signal-and tissue-specific activators allow different interactions with coactivators and with the basal transcriptional machinery, recruiting them to DNA to generate synergistic transcription (13, 39) . In the case of alveolar epithelial cells, we have demonstrated that NF-B is necessary and sufficient for activation of IL-8 transcription after TNF stimulation. In contrast, IL-8 induction by RSV infection requires the cooperation of various elements of the promoter. Among them we have identified a previously unrecognized ISRE-like regulatory element that plays an important role in RSV-activated IL-8 gene transcription.
